The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.
[EN] OXAZOLIDINONES AS MODULATORS OF MGLUR5<br/>[FR] OXAZOLIDINONES EN TANT QUE MODULATEURS DE MGLUR5
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012064603A1
公开(公告)日:2012-05-18
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.